CSPC Pharmaceutical Group Limited (CVG) — Cash Flow-to-Debt Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow-to-Debt Ratio of 0.25x as of June 2020, meaning its operating cash flow of €2.16 Billion could theoretically repay 0% of its total liabilities (€8.46 Billion) in one year. See CSPC Pharmaceutical Group Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CSPC Pharmaceutical Group Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for CSPC Pharmaceutical Group Limited across 13 annual periods. Also explore CSPC Pharmaceutical Group Limited (CVG) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year debt coverage analysis for CSPC Pharmaceutical Group Limited. For market capitalisation and broader financial context, see CSPC Pharmaceutical Group Limited market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | €5.83 Billion | €12.15 Billion | ▲ +11.4% |
| 2024 | 0.43x | €4.53 Billion | €10.52 Billion | ▲ +16.2% |
| 2023 | 0.37x | €4.18 Billion | €11.26 Billion | ▼ -50.7% |
| 2022 | 0.75x | €7.63 Billion | €10.13 Billion | ▲ +28.5% |
| 2021 | 0.59x | €4.64 Billion | €7.91 Billion | ▼ -39.4% |
| 2020 | 0.97x | €6.74 Billion | €6.97 Billion | ▲ +73.8% |
| 2019 | 0.56x | €3.78 Billion | €6.80 Billion | ▲ +12.5% |
| 2018 | 0.49x | €3.80 Billion | €7.67 Billion | ▼ -22.9% |
| 2017 | 0.64x | €3.29 Billion | €5.13 Billion | ▼ -10.0% |
| 2016 | 0.71x | €2.92 Billion | €4.09 Billion | ▲ +49.8% |
| 2015 | 0.48x | €2.25 Billion | €4.73 Billion | ▲ +14.6% |
| 2014 | 0.42x | €1.81 Billion | €4.35 Billion | ▲ +134.6% |
| 2013 | 0.18x | €814.86 Million | €4.60 Billion | — |